Gavin Baker’s ASML ASML Stock Holding History

Gavin Baker’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,657	Closed	-$13M	–	50
2025 Q1	$13M	Sell	19,657 -273,979	-93%	-$199M	0.4%	39
2024 Q4	$204M	Buy	+293,636	New	+$211M	4.46%	4

Other funds holding ASML

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gavin Baker's ASML Position: Q2 2025 in Review

Gavin Baker sold out of ASML (ASML) in Q2 2025, closing a stake of 19,657 shares — an estimated $13M sold.

Gavin Baker first reported a position in ASML in Q4 2024 and held it in 2 quarters. The position peaked at $204M in Q4 2024. 1,715 funds tracked by Wall St. Rank hold ASML as of Q2 2025.

Gavin Baker reported no remaining ASML position as of Q2 2025 after selling out during the quarter.
Gavin Baker sold 19,657 ASML shares in Q2 2025, an estimated $13M.
Gavin Baker first reported a position in ASML in Q4 2024 and held it in 2 quarters.
Gavin Baker's ASML position peaked at $204M in Q4 2024.
1,715 funds tracked by Wall St. Rank held ASML as of Q2 2025.

Based on Atreides Management's 13F filing for Q2 2025, filed 14 Aug 2025.